Transvaginal Mesh is a surgical mesh used in women for the treatment of Stress Urinary Incontinence (SUI) or Pelvic Organ Prolapse (POP). The transvaginal mesh is surgically implanted in the vagina and used to create what is sometimes called a pelvic sling or bladder sling. It is a metallic or polymeric screen intended to be implanted to reinforce soft tissue or bone weakness. Some of the well-known manufacturers of this medical device are Johnson & Johnson, C.R. Bard, American Medical Systems, Boston Scientific and others.
Risks Posed by Transvaginal Mesh Are Known
In October 2008, the Food and Drug Administration (FDA) issued a Public Health Notification to notify the public of adverse events related to the use of surgical mesh. In July 2011, the FDA issued an update on the safety and effectiveness of the transvaginal mesh finding that it has not seen any conclusive evidence that use of the mesh improves outcomes any more than traditional POP repair that does not use mesh and in fact may expose patients to greater risks.
Specifically, some of the complications associated with transvaginal mesh include:
- Erosion of the mesh through the vaginal tissue
- Exposure or extrusion of mesh, which may require surgical intervention
- Painful sexual intercourse (dyspareunia)
- Perforation or puncture of bladder, intestines and bowels
- Urinary problems
- Vaginal pain
- Vaginal bleeding
- Vaginal scarring and shortening
- Recurrent pelvic organ prolapse
Currently, there are hundreds, if not more, pending vaginal mesh claims for injuries sustained by innocent victims of these horrific side effects.